BIANCO, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 88.416
NA - Nord America 2.269
AS - Asia 984
SA - Sud America 121
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 91.841
Nazione #
IT - Italia 87.786
US - Stati Uniti d'America 2.235
SG - Singapore 366
CN - Cina 340
SE - Svezia 166
UA - Ucraina 140
DE - Germania 109
BR - Brasile 87
VN - Vietnam 76
FI - Finlandia 66
IN - India 51
GB - Regno Unito 48
HK - Hong Kong 36
FR - Francia 35
BD - Bangladesh 29
CA - Canada 18
MA - Marocco 17
PK - Pakistan 17
AR - Argentina 14
JP - Giappone 14
PL - Polonia 11
KR - Corea 10
MX - Messico 10
LT - Lituania 8
BE - Belgio 7
NL - Olanda 7
ID - Indonesia 6
RU - Federazione Russa 6
SA - Arabia Saudita 6
TN - Tunisia 6
VE - Venezuela 6
ZA - Sudafrica 6
EG - Egitto 5
ES - Italia 5
IQ - Iraq 5
NP - Nepal 5
TR - Turchia 5
AT - Austria 4
CO - Colombia 4
NG - Nigeria 4
PT - Portogallo 4
EU - Europa 3
JO - Giordania 3
KE - Kenya 3
PE - Perù 3
PH - Filippine 3
PY - Paraguay 3
AL - Albania 2
BB - Barbados 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
HU - Ungheria 2
IE - Irlanda 2
IL - Israele 2
KW - Kuwait 2
RO - Romania 2
TW - Taiwan 2
UY - Uruguay 2
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
CL - Cile 1
CM - Camerun 1
DJ - Gibuti 1
EC - Ecuador 1
GE - Georgia 1
GT - Guatemala 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
PA - Panama 1
RS - Serbia 1
SL - Sierra Leone 1
SV - El Salvador 1
UZ - Uzbekistan 1
YT - Mayotte 1
Totale 91.841
Città #
Cagliari 86.744
Uta 958
Singapore 223
Fairfield 198
Ashburn 195
Woodbridge 148
Chandler 128
Houston 110
San Jose 108
Nyköping 107
Seattle 98
Boardman 86
Dallas 85
Wilmington 85
Ann Arbor 78
Beijing 71
Dearborn 61
Cambridge 59
Jacksonville 55
Los Angeles 54
Helsinki 46
Shanghai 39
Hong Kong 35
Council Bluffs 33
New York 31
Santa Clara 28
Boston 27
Nanjing 25
Ho Chi Minh City 23
Lauterbourg 21
Dong Ket 18
The Dalles 18
Redwood City 17
Casablanca 16
Munich 15
Chennai 13
Hanoi 12
Shenyang 12
Hefei 11
London 11
San Diego 11
Buffalo 9
Mumbai 9
Phoenix 9
Seoul 9
Warsaw 9
Frankfurt am Main 8
Nanchang 8
Orem 8
San Francisco 8
Tianjin 8
Atlanta 7
Brussels 7
Hebei 7
Jiaxing 7
Mountain View 7
Multan 7
São Paulo 7
Tokyo 7
Changsha 6
Chicago 6
Herndon 6
Jinan 6
Verona 6
Amsterdam 5
Brooklyn 5
Jakarta 5
Mexico City 5
Rome 5
Zhengzhou 5
Columbus 4
Denver 4
Ibadan 4
Johannesburg 4
Lahore 4
Manchester 4
Montreal 4
Ottawa 4
Pune 4
Redmond 4
Rio de Janeiro 4
Sassari 4
Walnut 4
Amman 3
Auburn Hills 3
Betim 3
Caracas 3
Dhaka 3
Greater Noida 3
Guangzhou 3
Guarulhos 3
Jeddah 3
La Jolla 3
Ningbo 3
Norwalk 3
Portsmouth 3
Saint Petersburg 3
Toronto 3
Turku 3
Washington 3
Totale 90.417
Nome #
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro- 1H -indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 14.730
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida 5.066
Phenylpropenoids from Bupleurum fruticosum as Anti-Human Rhinovirus Species A Selective Capsid Binders 4.704
Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors 4.447
2-(2-cycloalkylidene hydrazin-1-yl)-4-aryl-1,3-thiazoles: a promising class of antifungal agents 4.419
Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6 4.332
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase 4.192
New 4-[(3-cyclohexyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzene-1-sulfonamides, synthesis and inhibitory activity toward carbonic anhydrase I, II, IX, XII 3.946
Drug design, synthesis, in vitro and in silico evaluation of selective monoaminoxidase B inhibitors based on 3-acetyl-2-dichlorophenyl-5-aryl-2,3-dihydro-1,3,4-oxadiazole chemical scaffold 3.786
Identification of Myricetin as Ebolavirus VP35-dsRNA interaction inhibitor through a novel fluorescence-based assay 3.757
Targeting tumor associated carbonic anhydrase IX and XII: Highly isozyme selective coumarin and psoralen inhibitors 3.544
Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 Reverse transcriptase-associated RNase H and RDDP functions 3.519
Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B 3.380
N-Acylbenzenesulfonamide dihydro-1,3,4-oxadiazole hybrids: seeking selectivity toward carbonic anhydrase isoforms 3.211
Tuning the Dual Inhibition of Carbonic Anhydrase and Cyclooxygenase by Dihydrothiazole Benzensulfonamides 3.049
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor 2.923
MD protocol validation for the study of MAOB-inhibitor complexes 2.789
In search of new antitumor agents through the combination of individually active moieties: construction of a [3,5-diaryl-(4,5- dihydropyrazol-1-yl)-4-oxo-1,3-thiazol-5-ylidene]- 1H-indol-2-ones library 2.754
Synthesis and biological activity evaluation of new dual-inhibitors of both associated functions of HIV-1 RT 2.659
Towards the total block of HIV-1 Reverse Transcriptase: the dual-inhibitors approach 2.614
Investigation on the mechanism of action of new dual inhibitors of HIV-1 RT 2.554
New dual inhibitors of RT associated functions: investigation on their mechanism and mode of action 2.458
Design, synthesis and biological activity evaluation of c-myc proto-oncogene binders as potential antitumor agents 2.082
Structure-based approaches applied to the study of pharmaceutical relevant targets 1.054
Totale 91.969
Categoria #
all - tutte 102.424
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.424


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021639 0 0 0 0 0 0 0 0 0 0 0 639
2021/20223.573 441 281 177 324 325 189 184 175 334 399 364 380
2022/20235.424 422 849 778 571 353 550 226 340 307 281 381 366
2023/20244.513 314 162 376 270 407 827 502 386 290 236 341 402
2024/202518.698 8.046 5.226 3.011 806 411 515 386 37 82 46 47 85
2025/20261.979 141 94 202 136 165 139 258 164 128 319 110 123
Totale 91.969